Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 1
2009 2
2010 3
2011 2
2012 3
2014 4
2015 2
2016 6
2017 8
2018 5
2019 3
2020 3
2021 5
2022 4
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

44 results

Results by year

Filters applied: . Clear all
Page 1
Gefitinib plus tremelimumab combination in refractory non-small cell lung cancer patients harbouring EGFR mutations: The GEFTREM phase I trial.
Riudavets M, Naigeon M, Texier M, Dorta M, Barlesi F, Mazieres J, Varga A, Cassard L, Boselli L, Grivel J, NgoCamus M, Lacroix L, Mezquita L, Besse B, Chaput N, Planchard D. Riudavets M, et al. Among authors: dorta m. Lung Cancer. 2022 Apr;166:255-264. doi: 10.1016/j.lungcan.2021.11.018. Epub 2021 Dec 3. Lung Cancer. 2022. PMID: 34953624 Clinical Trial.
Clinical Utility and Outcomes Impact of Crystal Digital PCR of Sensitizing and Resistance EGFR Mutations in Patients With Advanced Non-Small Cell Lung Cancer.
Riudavets M, Lamberts V, Vasseur D, Auclin E, Aldea M, Jovelet C, Naltet C, Lavaud P, Gazzah A, Aboubakar F, Dorta M, Remon J, Rouleau E, Ngocamus M, Nicotra C, Lacroix L, Besse B, Mezquita L, Planchard D. Riudavets M, et al. Among authors: dorta m. Clin Lung Cancer. 2022 Sep;23(6):e377-e383. doi: 10.1016/j.cllc.2022.05.010. Epub 2022 May 11. Clin Lung Cancer. 2022. PMID: 35660356
Alterations in monocyte subsets and cytokine production after TLR activation in American Cutaneous Leishmaniasis.
Quixabeira VBL, Pereira LIA, Veras PRV, da Costa ACV, Fonseca LG, Galdino H Jr, da Silva IA Jr, Morato CI, Pinto SA, Pereira AJCS, Dorta ML, Oliveira MAP, Gomes RS, Ribeiro-Dias F. Quixabeira VBL, et al. Among authors: dorta ml. Parasite Immunol. 2019 May;41(5):e12623. doi: 10.1111/pim.12623. Epub 2019 Apr 10. Parasite Immunol. 2019. PMID: 30870579
44 results